The optimum implementation of long-acting injectable cabotegravir-rilpivirine in sub-Saharan Africa
- PMID: 33770512
- DOI: 10.1016/S2214-109X(21)00052-8
The optimum implementation of long-acting injectable cabotegravir-rilpivirine in sub-Saharan Africa
Comment on
-
The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis.Lancet Glob Health. 2021 May;9(5):e620-e627. doi: 10.1016/S2214-109X(21)00025-5. Epub 2021 Mar 23. Lancet Glob Health. 2021. PMID: 33770513 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
